Patents by Inventor Kwang-ho Cha
Kwang-ho Cha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12178242Abstract: A smoking article case with a hand care function may be provided. The smoking article case according to some embodiments of the present disclosure includes a body portion in which an inner space for storing a smoking article is formed and a cover which is connected to the body portion, wherein a functional care zone may be formed on at least a portion of an outer surface of the body portion and an outer surface of the cover. Microcapsules containing a functional material are applied on the functional care zone, and as the microcapsules are crushed by a smoker's rubbing motion and the functional material is discharged from the crushed microcapsules, the hand care function may be provided to the smoker.Type: GrantFiled: November 12, 2021Date of Patent: December 31, 2024Assignee: KT&G CORPORATIONInventors: Kwang Ho Cha, Han Jin Kim, Chul Hee Lee, Chang Keun Im, Kyung Bin Jung, Nae Oh Chung
-
Patent number: 12168073Abstract: A percutaneous absorption preparation including donepezil for the treatment of dementia is disclosed. The percutaneous absorption preparation for the treatment of dementia includes a support layer, a drug-containing layer, and a release layer, wherein the drug-containing layer contains donepezil or a pharmaceutically acceptable salt thereof as an active ingredient; monothioglycerol, thiocyanate metal salt (preferably potassium salt) or dimethylthiourea as a stabilizer; and a pressure-sensitive adhesive. Also disclosed is a percutaneous absorption preparation for the treatment of dementia with reduced the formation of donepezil impurities.Type: GrantFiled: September 5, 2019Date of Patent: December 17, 2024Assignees: DONG-A ST CO., LTD., KM TRANSDERM LTD.Inventors: Sun-Woo Jang, Chang-Yell Shin, Hae-Sun Kim, Kwang-Ho Cha, Hyun-Jung Kim, Masaoki Goto
-
Publication number: 20240381925Abstract: Provided are a smoking article including a medium portion, and a filter portion, in which the medium portion includes cigar leaf tobacco and cigar expanded cut tobacco, and a method of manufacturing a smoking article the method including step S1 of manufacturing cigar expanded cut tobacco by expanding cigar leaf tobacco, step S2 of blending leaves of the cigar expanded cut tobacco and the cigar leaf tobacco, and step S3 of wrapping the cigar expanded cut tobacco and the cigar leaf tobacco with a printed cigar wrapper, in which an expansion temperature in step S1 is 180° C. to 350° C.Type: ApplicationFiled: May 15, 2024Publication date: November 21, 2024Applicant: KT&G CORPORATIONInventors: Chul Hee LEE, Hyung Ho GO, Kwang Ho CHA, Dong Kyun KO, Han Jin KIM
-
Patent number: 11992562Abstract: A percutaneous absorption preparation is disclosed. The percutaneous absorption preparation contains donepezil for treatment of dementia, wherein the preparation includes: (a) donepezil or its pharmaceutically acceptable salt as active component, (b) propylene glycol monocaprylate as solubilizer, and (c) styrene-isoprene-styrene block copolymer (“SIS”) as adhesive. The percutaneous absorption preparation has low skin irritation and high skin penetration.Type: GrantFiled: November 7, 2018Date of Patent: May 28, 2024Assignees: DONG-A ST CO., LTD., KM TRANSDERM LTD.Inventors: Sun-Woo Jang, Chang-Yell Shin, Jeong-Soo Kim, Hae-Sun Kim, Kwang-Ho Cha, Hyun-Jung Kim, Masaoki Goto
-
Publication number: 20230201131Abstract: A percutaneous absorption preparation for the treatment of dementia wherein the drug-containing layer contains donepezil or a pharmaceutically acceptable salt thereof as an active ingredient and a stabilizer that is either (i) a mixture of a thiocyanate salt and a compound selected from the group consisting of tea catechin, (+)-catechin, epigallocatechin gallate, ascorbic acid, and isoascorbic acid, or (ii) a mixture of monothioglycerol and a compound selected from the group consisting of tea catechin, (+)-catechin, epigallocatechin gallate, and ascorbic acid is disclosed. The percutaneous absorption preparation meets the criteria of Procedure 1 and Procedure 2 of the U.S. Pharmacopoeia in short-term stress test (70° C. 48 hours storage), long-term accelerated test 1 (40° C. relative humidity 75% 1 month storage), and long-term accelerated test 2 (40° C. relative humidity 75% 3 months storage), and exhibits improved stability for long-term preservation.Type: ApplicationFiled: May 12, 2021Publication date: June 29, 2023Applicants: DONG-A ST CO., LTD., KM TRANSDERM LTD.Inventors: Sun-Woo JANG, Chang-Yell SHIN, Hae-Sun KIM, Kwang-Ho CHA, Hyun-jung KIM, Sang-Min HYUN, Masaoki GOTO
-
Publication number: 20230157354Abstract: A smoking article case with a hand care function may be provided. The smoking article case according to some embodiments of the present disclosure includes a body portion in which an inner space for storing a smoking article is formed and a cover which is connected to the body portion, wherein a functional care zone may be formed on at least a portion of an outer surface of the body portion and an outer surface of the cover. Microcapsules containing a functional material are applied on the functional care zone, and as the microcapsules are crushed by a smoker's rubbing motion and the functional material is discharged from the crushed microcapsules, the hand care function may be provided to the smoker.Type: ApplicationFiled: November 12, 2021Publication date: May 25, 2023Applicant: KT&G CORPORATIONInventors: Kwang Ho CHA, Han Jin KIM, Chul Hee LEE, Chang Keun IM, Kyung Bin JUNG, Nae Oh CHUNG
-
Publication number: 20230043392Abstract: An embodiment of the present disclosure provides a method of flavoring and aging smoking materials, the method including: adding a flavoring, which is diluted in a base solution, to a smoking material; and aging the smoking material, to which the flavoring is added, under constant temperature and humidity conditions.Type: ApplicationFiled: September 15, 2021Publication date: February 9, 2023Applicant: KT&G CORPORATIONInventors: Chul Hee LEE, Kwang Ho CHA, Han Jin KIM, Nae Oh CHUNG, Jang Mi LEE, Chang Keun IM
-
Publication number: 20220386687Abstract: An embodiment of the present disclosure provides a smoking material wrapper which includes cigar fibers and at least one vanilla material from among vanillin, ethyl vanillin, and ethyl vanillin glucoside, and a smoking article including the same.Type: ApplicationFiled: July 2, 2021Publication date: December 8, 2022Applicant: KT&G CORPORATIONInventors: Nae Oh CHUNG, Ki Jin AHN, Chul Hee LEE, Han Jin KIM, Kwang Ho CHA, Kwang Won KANG
-
Publication number: 20220125096Abstract: An embodiment of the present disclosure provides a method of aging smoking materials for constituting at least a portion of a smoking material portion of a smoking article, the method including preparing an oak barrel and the smoking materials, putting the smoking materials into an inner space of the oak barrel, sealing the oak barrel, and aging the smoking materials.Type: ApplicationFiled: December 21, 2020Publication date: April 28, 2022Applicant: KT&G CORPORATIONInventors: Kwang Ho CHA, Chul Hee LEE, Han Jin KIM, Jang Mi LEE, Kwang Won KANG, Nae Oh CHUNG
-
Publication number: 20220047524Abstract: A percutaneous absorption preparation including donepezil for the treatment of dementia is disclosed. The percutaneous absorption preparation for the treatment of dementia includes a support layer, a drug-containing layer, and a release layer, wherein the drug-containing layer contains donepezil or a pharmaceutically acceptable salt thereof as an active ingredient; monothioglycerol, thiocyanate metal salt (preferably potassium salt) or dimethylthiourea as a stabilizer; and a pressure-sensitive adhesive. Also disclosed is a percutaneous absorption preparation for the treatment of dementia with reduced the formation of donepezil impurities.Type: ApplicationFiled: September 5, 2019Publication date: February 17, 2022Applicants: DONG-A ST CO., LTD, KM TRANSDERM LTD.Inventors: Sun-Woo JANG, Chang-Yell SHIN, Hae-Sun KIM, Kwang-Ho CHA, Hyun-Jung KIM, Masaoki GOTO
-
Publication number: 20210059956Abstract: A percutaneous absorption preparation is disclosed. The percutaneous absorption preparation contains donepezil for treatment of dementia, wherein the preparation includes: (a) donepezil or its pharmaceutically acceptable salt as active component, (b) propylene glycol monocaprylate as solubilizer, and (c) styrene-isoprene-styrene block copolymer (“SIS”) as adhesive. The percutaneous absorption preparation has low skin irritation and high skin penetration.Type: ApplicationFiled: November 7, 2018Publication date: March 4, 2021Applicants: DONG-A ST CO., LTD., KM TRANSDERM LTD.Inventors: Sun-Woo JANG, Chang-Yell SHIN, Jeong-Soo KIM, Hae-Sun KIM, Kwang-Ho CHA, Hyun-Jung KIM, Masaoki GOTO
-
Patent number: 9579261Abstract: Disclosed is a method for preparing a liposome formulation. In the disclosed method, a lipid fraction is dissolved in an organic solvent. The solution including a bioactive component and the lipid fraction, together with a carrier, is put in a reaction vessel, and a supercritical fluid is introduced thereto, so as to prepare particles coated with the bioactive component-lipid. The supercritical fluid is discharged by compression to obtain proliposome particles, and then the proliposome particles are hydrated by an aqueous solution including water so as to form a liposome solution. Preferably, the formulation may include one or more bioactive components. As required, the liposome formulation may be further processed by methods such as particle size reduction, removal of organic solvent, and freeze-drying. The preparation method can be easily carried out at a laboratory scale. Furthermore, the same method can be employed in liposome formulation preparation in mass production, or at a commercial scale.Type: GrantFiled: February 24, 2011Date of Patent: February 28, 2017Assignee: BCWORLD PHARM. CO., LTD.Inventors: Sung Joo Hwang, Hee Jun Park, Wonkyung Cho, Kwang-Ho Cha, Junsung Park, Chanhyuk Park, Donggeon Gu
-
Patent number: 9320801Abstract: Provided is an ophthalmic composition containing cyclosporine as an active ingredient and including polyethoxylated castor oil or polyethoxylated hydrogenated castor oil, and a method of preparing the same. Particularly, the ophthalmic composition is prepared as a nanoemulsion having a particle diameter of 100 nm or less simply by mixing and stirring an oil phase and an aqueous phase without using a high speed stirring or shearing machine, so that it is very physiochemically stable and storable for a long time. In addition, the ophthalmic composition causes no irritation to eyes.Type: GrantFiled: January 22, 2013Date of Patent: April 26, 2016Assignee: HUONS CO., LTDInventors: Sung Joon Wang, Kwang Ho Cha, Han Kang, Bo Kyung Sun
-
Publication number: 20160022818Abstract: The present invention provides a pharmaceutical formulation for increasing the dissolution rate of a lipase inhibitor and reducing side effects of the lipase inhibitor, including oily anal leakage, and a method for preparing the same, the pharmaceutical formulation comprising: a lipase inhibitor, and a porous adsorbent on which a thin film of the lipase inhibitor is formed.Type: ApplicationFiled: March 13, 2014Publication date: January 28, 2016Inventors: Sung-Joo HWANG, Kwang-Ho CHA, Bokyung SUN, Han KANG, In-ho SONG
-
Publication number: 20150125494Abstract: Provided is an ophthalmic composition containing cyclosporine as an active ingredient and including polyethoxylated castor oil or polyethoxylated hydrogenated castor oil, and a method of preparing the same. Particularly, the ophthalmic composition is prepared as a nanoemulsion having a particle diameter of 100 nm or less simply by mixing and stirring an oil phase and an aqueous phase without using a high speed stirring or shearing machine, so that it is very physiochemically stable and storable for a long time. In addition, the ophthalmic composition causes no irritation to eyes.Type: ApplicationFiled: January 22, 2013Publication date: May 7, 2015Inventors: Sung Joon Wang, Kwang Ho Cha, Han Kang, Bo Kyung Sun
-
Patent number: 8734830Abstract: The present invention relates to a novel technology for forming fine particles with a size of 0.0˜23 microns from a solid that can be dissolved in a liquid solvent and is not decomposed by heat. The particle preparation technology according to the present invention may be applicable to the fields of food, cosmetics, biopolymer, polymer compositions, and pharmaceuticals.Type: GrantFiled: March 3, 2010Date of Patent: May 27, 2014Assignee: Korea United Pharm. Inc.Inventors: Sung Joo Hwang, Min Soo Kim, Jeong Soo Kim, Kwang Ho Cha, Won Kyung Cho, Jun Sung Park, Suk Jun Seo
-
Publication number: 20130069261Abstract: Disclosed is a method for preparing a liposome formulation. In the disclosed method, a lipid fraction is dissolved in an organic solvent. The solution including a bioactive component and the lipid fraction, together with a carrier, is put in a reaction vessel, and a supercritical fluid is introduced thereto, so as to prepare particles coated with the bioactive component-lipid. The supercritical fluid is discharged by compression to obtain proliposome particles, and then the proliposome particles are hydrated by an aqueous solution including water so as to form a liposome solution. Preferably, the formulation may include one or more bioactive components. As required, the liposome formulation may be further processed by methods such as particle size reduction, removal of organic solvent, and freeze-drying. The preparation method can be easily carried out at a laboratory scale. Furthermore, the same method can be employed in liposome formulation preparation in mass production, or at a commercial scale.Type: ApplicationFiled: February 24, 2011Publication date: March 21, 2013Inventors: Sung Joo Hwang, Hee Jun Park, Wonkyung Cho, Kwang-Ho Cha, Junsung Park, Chanhyuk Park, Donggeon Gu
-
Publication number: 20110200678Abstract: The present invention relates to a novel technology for forming fine particles with a size of 0.02˜3 microns from a solid that can be dissolved in a liquid solvent and is not decomposed by heat. The particle preparation technology according to the present invention may be applicable to the fields of food, cosmetics, biopolymer, polymer compositions, and pharmaceuticals.Type: ApplicationFiled: March 3, 2010Publication date: August 18, 2011Applicant: THE INDUSTRY METHOD AND APPARATUS OF ULTRAFINE PARTICLES HAVING UNIFORM PARTICLE SIZE DISTRIBUTIOInventors: Sung Joo Hwang, Min Soo Kim, Jeong Soo Kim, Kwang Ho Cha, Won Kyung Cho, Jun Sung Park, Suk Jun Seo
-
Patent number: 7652264Abstract: A filament member configured to discharge thermions may be employed in an ion source of an ion implantation apparatus. A filament member may include an anode disposed around a central portion of the filament member, a cathode disposed around a periphery of the filament and/or enclosing the anode, and at least one conductive path disposed between the anode and the cathode to discharge the thermions.Type: GrantFiled: October 10, 2006Date of Patent: January 26, 2010Assignee: Samsung Electronics Co., Ltd.Inventors: Ui-Hui Kwon, Tai-Kyung Kim, Gyeong-Su Keum, Won-Young Chung, Kwang-Ho Cha
-
Patent number: D732540Type: GrantFiled: May 16, 2013Date of Patent: June 23, 2015Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Young-Min Kang, Byoung-Soo Lee, Jae-Woo Lee, Kwang-Soo Han, Kwang-Ho Cha